CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,871,004 | -10.1% | 267,176 | -0.5% | 0.00% | 0.0% |
Q2 2023 | $8,759,645 | -7.3% | 268,536 | +0.0% | 0.00% | 0.0% |
Q1 2023 | $9,448,726 | -22.7% | 268,506 | +0.7% | 0.00% | -40.0% |
Q4 2022 | $12,215,566 | -2.9% | 266,599 | +2.7% | 0.01% | 0.0% |
Q3 2022 | $12,574,000 | +31.5% | 259,510 | +6.7% | 0.01% | +66.7% |
Q2 2022 | $9,560,000 | +8.5% | 243,300 | +1.6% | 0.00% | 0.0% |
Q1 2022 | $8,811,000 | -5.0% | 239,355 | +17.6% | 0.00% | 0.0% |
Q4 2021 | $9,279,000 | +33.4% | 203,587 | +4.7% | 0.00% | +50.0% |
Q3 2021 | $6,954,000 | +125.6% | 194,449 | +24.8% | 0.00% | +100.0% |
Q2 2021 | $3,083,000 | -34.4% | 155,860 | -22.8% | 0.00% | -50.0% |
Q1 2021 | $4,697,000 | +12.7% | 201,926 | +0.7% | 0.00% | 0.0% |
Q4 2020 | $4,166,000 | -3.7% | 200,498 | +0.4% | 0.00% | 0.0% |
Q3 2020 | $4,324,000 | +9.0% | 199,744 | +18.7% | 0.00% | 0.0% |
Q2 2020 | $3,966,000 | +125.3% | 168,255 | +12.7% | 0.00% | +100.0% |
Q1 2020 | $1,760,000 | +11.7% | 149,358 | +0.6% | 0.00% | 0.0% |
Q4 2019 | $1,575,000 | +1.1% | 148,477 | +8.5% | 0.00% | 0.0% |
Q3 2019 | $1,558,000 | +2.4% | 136,880 | +1.2% | 0.00% | 0.0% |
Q2 2019 | $1,521,000 | +47.8% | 135,191 | +6.2% | 0.00% | 0.0% |
Q1 2019 | $1,029,000 | +43.7% | 127,273 | +11.0% | 0.00% | 0.0% |
Q4 2018 | $716,000 | -36.7% | 114,644 | -0.3% | 0.00% | 0.0% |
Q3 2018 | $1,132,000 | +38.4% | 114,983 | +16.2% | 0.00% | 0.0% |
Q2 2018 | $818,000 | +21.4% | 98,930 | +6.0% | 0.00% | 0.0% |
Q1 2018 | $674,000 | -8.2% | 93,305 | +3.7% | 0.00% | 0.0% |
Q4 2017 | $734,000 | -43.0% | 89,962 | +1.4% | 0.00% | 0.0% |
Q3 2017 | $1,287,000 | +27.6% | 88,742 | +6.7% | 0.00% | 0.0% |
Q2 2017 | $1,009,000 | +747.9% | 83,200 | +801.9% | 0.00% | – |
Q1 2017 | $119,000 | +3.5% | 9,225 | -1.1% | 0.00% | – |
Q4 2016 | $115,000 | +167.4% | 9,328 | +94.2% | 0.00% | – |
Q3 2016 | $43,000 | -6.5% | 4,803 | 0.0% | 0.00% | – |
Q2 2016 | $46,000 | +39.4% | 4,803 | 0.0% | 0.00% | – |
Q1 2016 | $33,000 | -34.0% | 4,803 | 0.0% | 0.00% | – |
Q4 2015 | $50,000 | – | 4,803 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |